Ocular Drug Metabolism of the Bioactivating Antioxidant N-acetylcarnosine for Vision in Ophthalmic Prodrug and Codrug Design and Delivery

REFERENCES

• H. Abe. (2000). Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Moscow) 65:757–765.
   PubMed Web of Science ®Google Scholar
• G. Aldini, M. Carini, G. Beretta, S. Bradamante, and R. M. Facino. (2002). Carnosine is a quencher of 4-hydroxy-nonenal: Through what mechanism of reaction?. Biochem. Biophys. Res. Commun. 298 (5):699–706.
   PubMed Web of Science ®Google Scholar
• A. M. Al-Ghananeem, and P. A. Crooks. (2007). Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. Molecules 12:373–388.
   PubMed Web of Science ®Google Scholar
• J. A. Anderson, W. L. Davis, and C. Wei. (1980). Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine. Invest. Ophthalmol. Vis. Sci. 19:817–823.
   PubMed Web of Science ®Google Scholar
• O. I. Aruoma, M. J. Laughton, and B. Halliwell. (1989). Carnosine, homocarnosine and anserine: Could they act as antioxidants in vivo?. Biochem. J. 264:863–869.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev. (1989a). Accumulation of lipid peroxidation products in human cataracts. Acta Ophthalmol. (Copenh.) 67:281–287.
   Google Scholar
• M. A. Babizhayev. (1989b). Antioxidant activity of L-carnosine, a natural histidine-containing dipeptide in crystalline lens. Biochim. Biophys. Acta 1004:363–371.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev. (1989c). Lipid fluorophores of the human crystalline lens with cataract. Graefe's Arch. Clin. Exp. Ophthalmol. 227:384–391.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev. (1996). Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing. Biochim. Biophys. Acta 1315:87–99.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, (2004a). Method for topical treatment of eye disease and composition and device for said treatment. PCT Patent application. International Publication Number WO 2004/028536 A1. International Publication Date 8 April 2004.
   Google Scholar
• M. A. Babizhayev. (2004b). Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops. Rejuvenation Res. 7:186–198.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev. (2006). Ophthalmic pharmacology of N-acetylcarnosine lubricant eye drops. J Pharmacol. Toxicol. 1 (3):201–233.
   Google Scholar
• M. A. Babizhayev, and E. Bozzo Costa. (1994). Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochim. Biophys. Acta 1225:326–337.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, and A. I. Deev. (1986). Free radical oxidation of lipids and thiol groups in the formation of a cataract. Biofizika 31 (1):109–114.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, and A. I. Deyev. (1989). Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim. Biophys. Acta 1004:124–133.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, and K. Meguro, (2004). Combined use of carnosinase inhibitor with l-carnosines and composition. WO 2004/064866 PCT/JP2004/000351. Filed 20 January 2003.
   Google Scholar
• M. A. Babizhayev, A. I. Deyev, and A. V. Chernikov. (1992). Peroxide-metabolizing systems of the crystalline lens. Biochim. Biophys. Acta 1138:11–19.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, A. I. Deyev, and V. I. Derevyagin. (1989). Morphometric evaluation of human lens opacification. J. Microsc. (Oxford) 154 (2):115–127.
   PubMedGoogle Scholar
• M. A. Babizhayev, A. I. Deyev, and L. F. Linberg. (1988). Lipid peroxidation as a possible cause of cataract. Mech. Ageing Dev. 44:69–89.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, A. I. Deyev, V. N. Yermakova, I. V. Brikman, and J. Bours. (2004). Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs R&D 5 (3):125–139.
   PubMedGoogle Scholar
• M. A. Babizhayev, A. I. Deyev, V. N. Yermakova, V. V. Remenshchikov, and J. Bours. (2006). Revival of the lens transparency with N-acetylcarnosine. Curr. Drug Ther. 1:91–116.
   Google Scholar
• M. A. Babizhayev, A. I. Deyev, V. N. Yermakova, Yu. A. Semiletov, N. G. Davydova, N. I. Kurysheva, A. V. Zhukotskii, and I. M. Goldman. (2001). N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides 22:979–994.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, A. I. Deyev, V. N. Yermakova, Yu. A. Semiletov, N. G. Davydova, V. S. Doroshenko, A. V. Zhukotskü, and I. M. Goldman. (2002). Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R&D 3 (2):87–103.
   PubMedGoogle Scholar
• M. A. Babizhayev, M-C. Seguin, J. Gueyne, R. P. Evstigneeva, E. A. Ageyeva, and G. A. Zheltukhina. (1994). L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem. J. 304:509–516.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, V. N. Yermakova, A. I. Deyev, and M-C. Seguin. (2000). Imidazole-containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans. J. Anti-Aging Med. 3:43–62.
   Google Scholar
• M. A. Babizhayev, V. N. Yermakova, N. L. Sakina, R. P. Evstigneeva, E. A. Rozhkova, and G. A. Zheltukhina. (1996). N-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin. Chim. Acta 254:1–21.
   PubMed Web of Science ®Google Scholar
• M. A. Babizhayev, V. N. Yermakova, Yu, A. Semiletov, and A. I. Deyev. (2000). The natural histidine-containing dipeptide N-acetylcarnosine as an antioxidant for ophthalmic use. Biochemistry (Moscow) 65:588–598.
   PubMed Web of Science ®Google Scholar
• E. Barbu, L. Verestiuk, T. G. Nevell, and J. Tsibouklis. (2006). Polymeric materials for ophthalmic drug delivery: Trends and perspectives. J. Mater. Chem. 16:3439–3443.
   Web of Science ®Google Scholar
• K. C. Bhuyan, and D. K. Bhuyan. (1984). Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr. Eye Res. 3:67–81.
   PubMed Web of Science ®Google Scholar
• A. A. Boldyrev. Carnosine. Biological significance and possibilities for application in medicine. Moscow State University, Moscow, (1998) 319.
   Google Scholar
• A. A. Boldyrev, A. M. Dupin, A. Ya. Bunin, M. A. Babizhayev, and S. E. Severin. (1987). The antioxidative properties of carnosine, a natural histidine containing dipeptide. Biochem. Int. 15:1105–1113.
   PubMedGoogle Scholar
• J. L. Bolland, and H. P. Koch. (1945). The course of autooxidation reactions in polyisoprenes and allied compounds. Part IX. The primary thermal oxidation products of ethyl linoleate. J. Chem. Soc. 7:445–447.
   Google Scholar
• J. A. Bonanno. (1996). Contact lens induced corneal acidosis. CLAO J. 22:70–74.
   PubMedGoogle Scholar
• P. S. Chen, T. Y. Toribara, and H. Warner. (1956). Microdetermination of phosphurus. Anal. Chem. 28:1756–1758.
   Web of Science ®Google Scholar
• K. S. Chio, and A. L. Tappel. (1969). Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry (Wash) 8:2821–2827.
   PubMed Web of Science ®Google Scholar
• S. Deejing, K. Yoshimune, S. Lumyong, and M. Moriguchi. (2005). Purification and characterization of hyperthermotolerant leucine aminopeptidase from Geobacillus thermoleovorans 47b. J. Ind. Microbiol. Biotechnol. 32 (7):269–276.
   PubMed Web of Science ®Google Scholar
• J. Folch, M. Lee, and G. H. S. Sloane-Stanely. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497–509.
   PubMed Web of Science ®Google Scholar
• B. Halliwell, and J. M. C. Gutteridge. Free radicals in biology and medicine. Clarendon, Oxford, (1985) .
   Google Scholar
• L. J. Hobart, I. Seibel, G. S. Yeargans, and N. W. Seidler. (2004). Anti-crosslinking properties of carnosine: Significance of histidine. Life Sci. 75 (11):1379–1389.
   PubMed Web of Science ®Google Scholar
• L. Huang, D. Tang, M. C. Yappert, and D. Borchman. (2006). Oxidation-induced changes in human lens epithelial cells 2. Mitochondria and the generation of reactive oxygen species. Free Radic. Biol. Med. 41 (6):926–936. Epub 2006 May 26.
   PubMed Web of Science ®Google Scholar
• J. L. Jay, D. J. Miller, J. D. Morrison, and J. J. O'Dowd. (1990). Histidyl derivatives in rabbit lens and their diminution in human cataract. Meeting Abstr. J. Physiol. Lond. 420:155.
   Google Scholar
• S. D. Kashi, and V. H. Lee. (1986). Hydrolysis of enkephalins in homogenates of anterior segment tissues of the albino rabbit eye. Invest. Ophthalmol. Vis. Sci. 27 (8):1300–1333.
   PubMed Web of Science ®Google Scholar
• J. M. Robertson. (1990). Cataract prevention: Time for a clinical trial?. Br. J. Clin. Pract. 44:475–476.
   PubMedGoogle Scholar
• H. Sasaki, C. Tei, K. Nishida, and J. Nakamura. (1995). Effect of ophthalmic preservatives on serum concentration and local irritation of ocularly applied insulin. Biol. Pharm. Bull. 18 (1):169–171.
   PubMed Web of Science ®Google Scholar
• H. Sasaki, K. Yamamura, T. Mukai, K. Nishida, J. Nakamura, M. Nakashima, and M. Ichikawa. (2000). Modification of ocular permeability of peptide drugs by absorption promoters. Bio. Pharm. Bull. 23 (12):1524–1527.
   PubMed Web of Science ®Google Scholar
• N. W. Seidler, G. S. Yeargans, and T. G. Morgan. (2004). Carnosine disaggregates glycated alpha-crystallin: An in vitro study. Arch. Biochem. Biophys. 427 (1):110–115.
   PubMed Web of Science ®Google Scholar
• K. K. Sharma, and B. J. Ortwerth. (1987). Purification and characterization of an aminopeptidase from bovine cornea. Exp. Eye Res. 45 (1):117–126.
   PubMed Web of Science ®Google Scholar
• Stewart, J. J. (1989b). MOPAC. Ver.6, QCPE Bull. 9,10. Revised as Ver. 6.01 by T. Hirano, University of Tokyo, for HITAC and UNIX machines (JCPE Newsletter, 1989. 1,10).
   Google Scholar
• J. J. P. Stewart. MOPAC. F. J. Seiler Research Laboratory. US Air Force Academy, BoulderCO80840 USA, (1989a) .
   Google Scholar
• M. Testa, G. Iuliano, P. Morton, and A. Longoni. (1987). Topical benzyl alcohol reduces cataract surgery need: two long-term double blind studies. J. Ocul. Pharmacol. 3 (3):211–225.
   PubMedGoogle Scholar